← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Biochemanalysis Corporation
Chicago, IL
$4,251,004
Total funding
12
Grants
Funding over time
peak $600.5K · FY2005–14$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$4,251,004 · 12
By mechanism
R44$2,668,553 · 3
R43$1,582,451 · 9
Investigators at Biochemanalysis Corporation
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Accurate Noninvasive Test of Steatorrhea in Infants$328,531
R44 · FY2002 · DK
Non-invasive Assessment of Skeletal Muscle Loss in Cancer Patients$303,761
R44 · FY2012 · AR
Non-invasive Assessment of Skeletal Muscle Loss in Cancer Patients$301,159
R44 · FY2014 · AR
Non-invasive Assessment of Skeletal Muscle Loss in Cancer Patients$301,159
R44 · FY2013 · AR
Non-invasive Assessment of Insulin Resistance$295,293
R44 · FY2011 · DK
Accurate Noninvasive Test of Steatorrhea in Infants$292,503
R44 · FY2003 · DK
Non-invasive Assessment of Insulin Resistance$286,755
R44 · FY2010 · DK
Accurate Noninvasive Test of Steatorrhea in Infants$280,923
R44 · FY2004 · DK
Non-invasive Assessment of Insulin Resistance$278,469
R44 · FY2009 · DK
Non-invasive Assessment of Skeletal Muscle Loss in Cancer Patients$207,050
R43 · FY2008 · AR
A Non-Invasive Surrogate Test of OGTT to Screen for Pre-diabetes$204,345
R43 · FY2008 · DK
Non-invasive Assessment of Insulin Resistance$202,652
R43 · FY2005 · DK
Long-term Iron Needs of Renal Transplant Recipients$199,176
R43 · FY2005 · DK
A Test of Iron Malabsorption in Patients with IDA$198,623
R43 · FY2005 · DK
Effective Oral Iron Supplement for Pre-dialysis Patients$177,483
R43 · FY2003 · DK
A STRATEGY TO PREVENT IRON OVERLOAD IN HEMOCHROMATOSIS$132,205
R43 · FY2000 · DK
ASSESSING MUCOSAL SURFACE AREA IN CELIAC DISEASE$131,874
R43 · FY2000 · DK
BORDERLINE PANCREATIC FUNCTION IN CYSTIC FIBROSIS$129,043
R43 · FY2000 · DK